ABO blood group and breast cancer incidence and survival

International Journal of Cancer

Volumn 130, Issue 9, 2012, Pages 2129-2137

  Gates, Margaret A ^a,b   Xu, Mousheng ^b   Chen, Wendy Y ^a,c   Kraft, Peter ^b   Hankinson, Susan E ^a,b   Wolpin, Brian M ^a,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

ABO blood group; ABO genotype; blood type; breast cancer; survival

Indexed keywords

AROMATASE INHIBITOR; TAMOXIFEN;

ADULT; AGE; AGED; ARTICLE; BLOOD GROUP A; BLOOD GROUP AB; BLOOD GROUP ABO SYSTEM; BLOOD GROUP B; BLOOD GROUP O; BLOOD GROUP TYPING; BREAST CANCER; CANCER INCIDENCE; CANCER INVASION; CANCER MORTALITY; CANCER SURVIVAL; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENETIC ANALYSIS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; SELF REPORT; SEROLOGY;

ABO BLOOD-GROUP SYSTEM; ADULT; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 84862777311     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26220     Document Type: Article

References (48)

1. Vogel F,. Controversy in human genetics. ABO blood groups and disease. Am J Hum Genet 1970; 22: 464-75.
2. Aird I, Bentall HH, Roberts JA,. A relationship between cancer of stomach and the ABO blood groups. Br Med J 1953; 1: 799-801.
3. Wolpin BM, Chan AT, Hartge P, Chanock SJ, Kraft P, Hunter DJ, Giovannucci EL, Fuchs CS,. ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst 2009; 101: 424-31.
4. Wolpin BM, Kraft P, Gross M, Helzlsouer K, Bueno-de-Mesquita HB, Steplowski E, Stolzenberg-Solomon RZ, Arslan AA, Jacobs EJ, Lacroix A, Petersen G, Zheng W, et al. Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium. Cancer Res 2010; 70: 1015-23.
5. Ben Q, Wang K, Yuan Y, Li Z,. Pancreatic cancer incidence and outcome in relation to ABO blood groups among Han Chinese patients: a case-control study. Int J Cancer 2010; 128: 1179-86.
6. Viste A, Eide GE, Halvorsen K, Maartmann-Moe H, Soreide O,. The prognostic value of Lauren's histopathological classification system and ABO blood groups in patients with stomach carcinoma. Eur J Surg Oncol 1986; 12: 135-41.
7. Moldvay J, Scheid P, Wild P, Nabil K, Siat J, Borrelly J, Marie B, Farre G, Labib T, Pottier G, Sesboue R, Bronner C, et al. Predictive survival markers in patients with surgically resected non-small cell lung carcinoma. Clin Cancer Res 2000; 6: 1125-34.
8. Edgren G, Hjalgrim H, Rostgaard K, Norda R, Wikman A, Melbye M, Nyren O,. Risk of gastric cancer and peptic ulcers in relation to ABO blood type: a cohort study. Am J Epidemiol 2010; 172: 1280-5.
9. Aird I, Bentall HH, Mehigan JA, Roberts JA,. The blood groups in relation to peptic ulceration and carcinoma of colon, rectum, breast, and bronchus; an association between the ABO groups and peptic ulceration. Br Med J 1954; 2: 315-21.
10. Goldenberg IS, Hayes MA,. Breast carcinoma and ABO blood groups. Cancer 1958; 11: 973-4.
11. Newell GR, Gordon JE, Monlezun AP, Horwitz JS,. ABO blood groups and cancer. J Natl Cancer Inst 1974; 52: 1425-30.
12. Ronco AL, Stoll M, De Stefani E, Maisonneuve JE, Mendoza BA, Deneo-Pellegrini H,. Rh factor, family history and risk of breast cancer: a case-control study in Uruguay. Cancer Detect Prev 2009; 32: 277-85.
13. Stamatakos M, Kontzoglou K, Safioleas P, Safioleas C, Manti C, Safioleas M,. Breast cancer incidence in Greek women in relation to ABO blood groups and Rh factor. Int Semin Surg Oncol 2009; 6: 14.
14. Anderson DE, Haas C,. Blood type A and familial breast cancer. Cancer 1984; 54: 1845-9.
15. Tryggvadottir L, Tulinius H, Robertson JM,. Familial and sporadic breast cancer cases in Iceland: a comparison related to ABO blood groups and risk of bilateral breast cancer. Int J Cancer 1988; 42: 499-501.
16. Jakoubkova J, Majsky A,. Blood groups and neoplastic disease. Neoplasma 1965; 12: 611-6.
17. Dede DS, Aksoy S, Dizdar O, Cerci P, Gullu I, Ozisik Y, Altundag K,. Blood ABO groups and risk of breast cancer. Med Oncol 2010; 27: 1433.
18. Torti RA,. Abo blood groups and Rh. Antigens in patients with carcinoma of the breast. Med Times 1963; 91: 1167-8.
19. Holdsworth PJ, Thorogood J, Benson EA, Clayden AD,. Blood group as a prognostic indicator in breast cancer. Br Med J (Clin Res Ed) 1985; 290: 671-3.
20. Costantini M, Fassio T, Canobbio L, Landucci M, Resasco M, Boccardo F,. Role of blood groups as prognostic factors in primary breast cancer. Oncology 1990; 47: 308-12.
21. Munzarova M, Kovarik J, Hlavkova J, Kolcova V,. Course of breast cancer disease and ABO blood groups. Biomed Pharmacother 1985; 39: 486-9.
22. Yazer MH,. What a difference 2 nucleotides make: a short review of ABO genetics. Transfus Med Rev 2005; 19: 200-9.
23. Strauchen JA, Bergman SM, Hanson TA,. Expression of A and B tissue isoantigens in benign and malignant lesions of the breast. Cancer 1980; 45: 2149-55.
24. Vowden P, Lowe AD, Lennox ES, Bleehen NM,. The expression of ABH and Y blood group antigens in benign and malignant breast tissue: the preservation of the H and Y antigens in malignant epithelium. Br J Cancer 1986; 53: 313-9.
25. Shull JH, Javadpour N, Soares T, Demoss EV,. The ABO(H) cell surface antigens in carcinoma and benign lesions of the breast. J Surg Oncol 1981; 18: 193-6.
26. Idikio HA, Manickavel V,. Lewis blood group antigens (a and b) in human breast tissues. Loss of Lewis-b in breast cancer cells and correlation with tumor grade. Cancer 1991; 68: 1303-8.
27. Nakagoe T, Fukushima K, Itoyanagi N, Ikuta Y, Oka T, Nagayasu T, Ayabe H, Hara S, Ishikawa H, Minami H,. Expression of ABH/Lewis-related antigens as prognostic factors in patients with breast cancer. J Cancer Res Clin Oncol 2002; 128: 257-64.
28. Colditz GA, Hankinson SE,. The Nurses' Health Study: lifestyle and health among women. Nat Rev Cancer 2005; 5: 388-96.
29. Hankinson SE, Willett WC, Manson JE, Hunter DJ, Colditz GA, Stampfer MJ, Longcope C, Speizer FE,. Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. J Natl Cancer Inst 1995; 87: 1297-302.
30. Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, Hankinson SE, Wacholder S, Wang Z, Welch R, Hutchinson A, Wang J, Yu K, et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 2007; 39: 870-4.
31. Kraft P, Cox DG, Paynter RA, Hunter D, De Vivo I,. Accounting for haplotype uncertainty in matched association studies: a comparison of simple and flexible techniques. Genet Epidemiol 2005; 28: 261-72.
32. Pare G, Chasman DI, Kellogg M, Zee RY, Rifai N, Badola S, Miletich JP, Ridker PM,. Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6,578 women. PLoS Genet 2008; 4: e1000118.
33. Rich-Edwards JW, Corsano KA, Stampfer MJ,. Test of the National Death Index and Equifax nationwide death search. Am J Epidemiol 1994; 140: 1016-9.
34. Stampfer MJ, Willett WC, Speizer FE, Dysert DC, Lipnick R, Rosner B, Hennekens CH,. Test of the National Death Index. Am J Epidemiol 1984; 119: 837-9.
35. Garratty G, Glynn SA, McEntire R,. ABO and Rh(D) phenotype frequencies of different racial/ethnic groups in the United States. Transfusion 2004; 44: 703-6.
36. Hartmann O, Stavem P,. ABO blood-groups and cancer. Lancet 1964; 1: 1305-6.
37. Majupuria KC, Gupta SR, Gupta LC,. The study of ABO blood groups and relationship with cancer breast (a preliminary report). Indian J Cancer 1966; 3: 182-3.
38. Rai S, Saronwala KC, Mittal PK, Arora S,. ABO blood group distribution in carcinoma of the breast. Indian J Cancer 1970; 7: 135-9.
39. Risch HA, Yu H, Lu L, Kidd MS,. ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: a case-control study. J Natl Cancer Inst 2010; 102: 502-5.
40. Iodice S, Maisonneuve P, Botteri E, Sandri MT, Lowenfels AB,. ABO blood group and cancer. Eur J Cancer 2010; 46: 3345-50.
41. Reid ME, Mohandas N,. Red blood cell blood group antigens: structure and function. Semin Hematol 2004; 41: 93-117.
42. Hakomori S,. Antigen structure and genetic basis of histo-blood groups A, B and O: their changes associated with human cancer. Biochim Biophys Acta 1999; 1473: 247-66.
43. Le Pendu J, Marionneau S, Cailleau-Thomas A, Rocher J, Le Moullac-Vaidye B, Clement M,. ABH and Lewis histo-blood group antigens in cancer. APMIS 2001; 109: 9-31.
44. Melzer D, Perry JR, Hernandez D, Corsi AM, Stevens K, Rafferty I, Lauretani F, Murray A, Gibbs JR, Paolisso G, Rafiq S, Simon-Sanchez J, et al. A genome-wide association study identifies protein quantitative trait loci (pQTLs). PLoS Genet 2008; 4: e1000072.
45. Barbalic M, Dupuis J, Dehghan A, Bis JC, Hoogeveen RC, Schnabel RB, Nambi V, Bretler M, Smith NL, Peters A, Lu C, Tracy RP, et al. Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels. Hum Mol Genet 2010; 19: 1863-72.
46. Paterson AD, Lopes-Virella MF, Waggott D, Boright AP, Hosseini SM, Carter RE, Shen E, Mirea L, Bharaj B, Sun L, Bull SB,. Genome-wide association identifies the ABO blood group as a major locus associated with serum levels of soluble E-selectin. Arterioscler Thromb Vasc Biol 2009; 29: 1958-67.
47. Qi L, Cornelis MC, Kraft P, Jensen M, van Dam RM, Sun Q, Girman CJ, Laurie CC, Mirel DB, Hunter DJ, Rimm E, Hu FB,. Genetic variants in ABO blood group region, plasma soluble E-selectin levels, and risk of type 2 diabetes. Hum Mol Genet 2010; 19: 1856-62.
48. Grivennikov SI, Greten FR, Karin M,. Immunity, inflammation, and cancer. Cell 2010; 140: 883-99.